|
COPA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.102100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.750200E-01 |
| Normal-vs-Stage2 |
4.762600E-01 |
| Normal-vs-Stage3 |
4.135500E-02 |
| Normal-vs-Stage4 |
6.402200E-02 |
| Stage1-vs-Stage2 |
8.488400E-01 |
| Stage1-vs-Stage3 |
1.450630E-01 |
| Stage1-vs-Stage4 |
1.963020E-01 |
| Stage2-vs-Stage3 |
4.039400E-01 |
| Stage2-vs-Stage4 |
4.455600E-01 |
| Stage3-vs-Stage4 |
8.977000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.783400E-01 |
| Normal-vs-AfricanAmerican |
2.570300E-04 |
| Normal-vs-Asian |
9.698600E-01 |
| Caucasian-vs-AfricanAmerican |
5.920200E-03 |
| Caucasian-vs-Asian |
8.045000E-01 |
| AfricanAmerican-vs-Asian |
1.671960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.022190E-02 |
| Normal-vs-Female |
8.592600E-01 |
| Male-vs-Female |
2.808100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.644600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.589200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.466400E-02 |
| Normal-vs-Age(81-100Yrs) |
6.358200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.642200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.264400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.917800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.790200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.970400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.095200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.052980E-01 |
| Normal-vs-Grade 2 |
3.894400E-01 |
| Normal-vs-Grade 3 |
7.398100E-02 |
| Normal-vs-Grade 4 |
9.362100E-03 |
| Grade 1-vs-Grade 2 |
1.791150E-01 |
| Grade 1-vs-Grade 3 |
2.812400E-02 |
| Grade 1-vs-Grade 4 |
2.741900E-02 |
| Grade 2-vs-Grade 3 |
3.107600E-01 |
| Grade 2-vs-Grade 4 |
3.718200E-02 |
| Grade 3-vs-Grade 4 |
2.225400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.153570E-01 |
| Normal-vs-ccB subtype |
1.230230E-02 |
| ccA subtype-vs-ccB subtype |
1.225870E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.255400E-01 |
| Normal-vs-N1 |
6.343200E-01 |
| N0-vs-N1 |
3.040000E-01 |
|
|
